
PRAME, CT (Preferently Expressed Antigen of Melanoma, Melanoma Antigen Preferentiële Uitdrukking in Tumoren, MAPE, CT130, OPA Interacting Protein 4, OPA-interactief Proteïne 4, Opa-interactief Proteïne OIP4, OIP4) (MaxLight 650)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
9007-83-4
[PRAME]
23532
Human
Store product at 4 degree C in the dark. DO NOT FREEZE! Stable at 4 degree C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight650 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Recognizes human MAPE.
[PRAME; PRAME; MAPE; OIP4; CT130; OIP-4; MAPE; OIP4; OIP-4]
[PRAME]
[melanoma antigen preferentially expressed in tumors isoform a; Melanoma antigen preferentially expressed in tumors; melanoma antigen preferentially expressed in tumors; Opa-interacting protein OIP4; cancer/testis antigen 130; opa-interacting protein 4; preferentially expressed antigen of melanoma; preferentially expressed antigen in melanoma; Opa-interacting protein 4; OIP-4; Preferentially expressed antigen of melanoma]
5174641
NP_006106
NM_006115
P78395
Beschrijving
PRAME, CT (Preferently Expressed Antigen of Melanoma, Melanoma Antigen Preferentiële Uitdrukking in Tumoren, MAPE, CT130, OPA Interacting Protein 4, OPA-interac
Specificaties
Recent bekeken producten

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

Erdafitinib
B2458-25
25 mg

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS

